US Pharma MarketingTakeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1
Takeda has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Orzeyful to treat narcolepsy type 1 in adults.
Takeda has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Orzeyful to treat narcolepsy type 1 in adults.
Source: Pharmaceutical Technology